Tanta University: Breast Neoplasms trials

The registry lists 11 Breast Neoplasms studies with Tanta University as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 7Phase 3 4Phase 4 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DICRecruitingNCT07436663Phase 4
• Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsNot yet recruitingNCT07370506Phase 1/2
• Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced CardiotoxicityRecruitingNCT06427226Phase 2
• Vitamin D and Calcium Supplementation in Breast CancerRecruitingNCT05523609Phase 2/3
• Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer PatientsCompletedNCT07137793Phase 2
• Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer PatientsCompletedNCT06155331Phase 2
• Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer PatientsStatus unknownNCT05595109Phase 2/3
• The Anti-tumor Effect of Metformin And Atorvastatin in Breast CancerStatus unknownNCT05507398Phase 4
• Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer PatientsCompletedNCT05338723Phase 3
• Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer WomenCompletedNCT05053841Phase 2
• The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast CancerCompletedNCT04874935Phase 3